01/10/2014 10:16:27 Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

DateTimeSource
Headline
09/30/20147:00AMPRNUSInovio Pharmaceuticals Appoints Vice President of Commercial Development
Inovio Pharmaceuticals Appoints Vice President of Commercial Development New Executive Brings Experience from Merck, Boehringer Ingelheim, and Proctor & Gamble PR Newswire PLYMOUTH MEETING, Pa., Sept. 30, 2014 PLYMOUTH MEETING, Pa., Sept. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced... More...>>
09/24/201410:41AMDJNCorrection to Inovio, GeneOne Headline
"Inovia, GeneOne to Advance Ebola Vaccine to Human Trials," at 8:41 a.m. EDT, misstated the name of company in the headline. The company is Inovio, not Inovia. Subscribe to WSJ: http://online.wsj.com?mod=djnwires More...>>
09/24/20149:50AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Wednesday's session are Citizens Financial Group Inc. (CFG), Newell Rubbermaid Inc. (NWL) and Acorda Therapeutics Inc. (ACOR). Citizens Financial, a U.S. unit of Royal Bank of Scotland Group PLC (RBS, RBS.LN), is expected to begin trading on Wednesday after... More...>>
09/24/20146:00AMPRNUSInovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science
Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science PR Newswire PLYMOUTH MEETING, Pa., Sept. 24, 2014 PLYMOUTH MEETING, Pa., Sept. 24, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in... More...>>
09/22/20148:00AMPRNUSInovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers Expansion Comes After Successful Phase II Trial for Cervical Dysplasia PR Newswire PLYMOUTH MEETING, Pa., Sept. 22, 2014 PLYMOUTH MEETING, Pa., Sept. 22, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today... More...>>
09/18/20146:00AMPRNUSInovio to Present at Upcoming Investor Conferences
Inovio to Present at Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Sept. 18, 2014 PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury's... More...>>
09/04/20149:00AMPRNUSInovio Pharmaceuticals to List on NASDAQ
Inovio Pharmaceuticals to List on NASDAQ PR Newswire PLYMOUTH MEETING, Pa., Sept. 4, 2014 PLYMOUTH MEETING, Pa., Sept. 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has met the listing criteria for the NASDAQ Global Select Market and will transfer its U.S. stock exchange... More...>>
09/03/20148:00AMPRNUSInovio to Present at Upcoming Investor Conferences
Inovio to Present at Upcoming Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Sept. 3, 2014 PLYMOUTH MEETING, Pa., Sept. 3, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the... More...>>
08/11/20148:30AMPRNUSInovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results HPV Immune Therapy VGX-3100 to Advance into Phase III PR Newswire PLYMOUTH MEETING, Penn., Aug. 11, 2014 PLYMOUTH MEETING, Penn., Aug. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter... More...>>
08/06/20145:16PMPRNUSINOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible...
INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc. PR Newswire NEW YORK, Aug. 6, 2014 NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating... More...>>
08/01/20148:00AMPRNUSInovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 PR Newswire PLYMOUTH MEETING, Pa., Aug. 1, 2014 PLYMOUTH MEETING, Pa., Aug. 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014... More...>>
07/23/20149:15AMPRNUSInovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PR Newswire PLYMOUTH MEETING, Pa., July 23, 2014 PLYMOUTH MEETING... More...>>
07/01/20144:00AMPRNUSInovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes
Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes Inovio Shares Enter No. 1 U.S. Equity Index for Asset Benchmarking PR Newswire PLYMOUTH MEETING, Pa., July 1, 2014 PLYMOUTH MEETING, Pa., July 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that... More...>>
06/23/20144:00AMPRNUSInovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial
Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial Inovio's Immunotherapy will Treat Women with Inoperable HPV-caused Cancer PR Newswire BLUE BELL, Pa., June 23, 2014 BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical... More...>>
06/17/20144:00AMPRNUSInovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania
Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania Expanded License Includes New Product Candidates for Cancer, Infectious Diseases and Novel Immune Activators PR Newswire BLUE BELL, Pa., June 17, 2014 BLUE BELL, Pa., June 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals... More...>>
06/16/20144:00AMPRNUSInovio Pharmaceuticals to Present at Upcoming Healthcare Conferences
Inovio Pharmaceuticals to Present at Upcoming Healthcare Conferences PR Newswire BLUE BELL, Pa., June 16, 2014 BLUE BELL, Pa., June 16, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President & CEO, Dr. J. Joseph Kim, will participate in a panel at the Piper Jaffray GenomeRx... More...>>
06/11/20149:00AMPRNUSInovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology
Inovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology Inovio Responds to False and Misleading Speculation Regarding Immunotherapy Study PR Newswire BLUE BELL, Pa., June 11, 2014 BLUE BELL, Pa., June 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) wishes... More...>>
06/10/20144:00AMPRNUSInovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV
Inovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV Inovio Targets Most Rapidly Increasing Cancer in Men PR Newswire BLUE BELL, Pa., June 10, 2014 BLUE BELL, Pa., June 10, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase... More...>>
05/30/20144:00AMPRNUSInovio Pharmaceuticals Announces Reverse Stock Split Date
Inovio Pharmaceuticals Announces Reverse Stock Split Date PR Newswire BLUE BELL, Pa., May 30, 2014 BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014... More...>>
05/27/20144:00AMPRNUSInovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Chall...
Inovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Challenge Protection Data Presented at the 17th Annual Meeting of the American Society of Gene & Cell Therapy PR Newswire BLUE BELL, Pa., May 27, 2014 BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino141001 10:16